Author:
Oktarianti R,Damara D R,Qudsiyah S U R,Wathon S,Senjarini K
Abstract
Abstract
The mosquito species Ae. aegyptiand Ae. albopictusare two potential vectors of dengue fever. The salivary glands of these species contain substances that play a role in the transmission of pathogens. These include vasodilators and immunomodulatory compounds. Immunomodulatory components can modulate the host immune system by producing specific antibodies (IgG). This study aims to investigate the human immune response (IgG) against the salivary gland extract of Ae. aegyptiand Ae. albopictus. Samples were collected from individuals who were Dengue patients, as well as healthy individuals and neonates from the Jember endemic area. Results show that the levels of IgG response vary across the individual. Generally, Dengue patients and healthy people in the DHF-endemic area had higher levels of IgG. The highest immune response was found in DHF patients, followed by healthy persons, and finally the neonate samples, respectively.
Reference31 articles.
1. Dengue vaccine;Simasathien;J. Med.Assoc.Thai,2005
2. Arthropodborne diseases: vector control in the genomics era;Hill;Nat. Rev. Microbiol.,2005
3. Transmission Blocking Vaccines to Control Insect-Borne Diseases - A Review;Abreu;Mem.Inst. Oswaldo Cruz,2010
4. Dengue Vaccine Approach the Finish Line. Center for Vaccine Development, University of Maryland School of Medicine Baltimore St;Edelman;CID,2007
5. Review of dengue virus and the development of vaccine;Murrel;Biotechnology Advances.,2011